Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 168 Pages
Report ld: 5344924
Request Sample
Customized Report
Glass Containers for Pharmaceutical Use Market Size(US$)

CAGR 2025-2031
3.9%
Market Size,2031
USD 4,923
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Glass Containers for Pharmaceutical Use market is projected to grow from US$ 3780 million in 2024 to US$ 4923 million by 2031, at a CAGR of 3.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Pharmaceutical Glass Packaging has a broad range of containers, including injectable, transfusion, diagnostic and syrup bottles, and offers a choice of glass type (I, II, III) and color (clear or amber) .
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Glass Containers for Pharmaceutical Use market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the Glass Containers for Pharmaceutical Use study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Glass Containers for Pharmaceutical Use: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Glass Containers for Pharmaceutical Use Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Glass Vials
1.2.3 Ampoules
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Glass Containers for Pharmaceutical Use Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Injectable
1.3.3 Transfusion
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Glass Containers for Pharmaceutical Use Revenue Estimates and Forecasts 2020-2031
2.2 Global Glass Containers for Pharmaceutical Use Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Glass Containers for Pharmaceutical Use Sales Estimates and Forecasts 2020-2031
2.4 Global Glass Containers for Pharmaceutical Use Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Glass Containers for Pharmaceutical Use Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Glass Containers for Pharmaceutical Use Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Glass Vials Market Size by Manufacturers
3.5.2 Ampoules Market Size by Manufacturers
3.5.3 Others Market Size by Manufacturers
3.6 Global Glass Containers for Pharmaceutical Use Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Glass Containers for Pharmaceutical Use Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Glass Containers for Pharmaceutical Use Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Glass Containers for Pharmaceutical Use Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Glass Containers for Pharmaceutical Use Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Glass Containers for Pharmaceutical Use Sales and Revenue by Type (2020-2031)
6.4 North America Glass Containers for Pharmaceutical Use Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Glass Containers for Pharmaceutical Use Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Glass Containers for Pharmaceutical Use Sales and Revenue by Type (2020-2031)
7.4 Europe Glass Containers for Pharmaceutical Use Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Glass Containers for Pharmaceutical Use Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Glass Containers for Pharmaceutical Use Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Glass Containers for Pharmaceutical Use Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Glass Containers for Pharmaceutical Use Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Glass Containers for Pharmaceutical Use Sales and Revenue by Type (2020-2031)
9.4 Central and South America Glass Containers for Pharmaceutical Use Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Glass Containers for Pharmaceutical Use Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Glass Containers for Pharmaceutical Use Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Glass Containers for Pharmaceutical Use Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Glass Containers for Pharmaceutical Use Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Gerresheimer
11.1.1 Gerresheimer Corporation Information
11.1.2 Gerresheimer Business Overview
11.1.3 Gerresheimer Glass Containers for Pharmaceutical Use Product Models, Descriptions and Specifications
11.1.4 Gerresheimer Glass Containers for Pharmaceutical Use Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Gerresheimer Glass Containers for Pharmaceutical Use Sales by Product in 2024
11.1.6 Gerresheimer Glass Containers for Pharmaceutical Use Sales by Application in 2024
11.1.7 Gerresheimer Glass Containers for Pharmaceutical Use Sales by Geographic Area in 2024
11.1.8 Gerresheimer Glass Containers for Pharmaceutical Use SWOT Analysis
11.1.9 Gerresheimer Recent Developments
11.2 Schott
11.2.1 Schott Corporation Information
11.2.2 Schott Business Overview
11.2.3 Schott Glass Containers for Pharmaceutical Use Product Models, Descriptions and Specifications
11.2.4 Schott Glass Containers for Pharmaceutical Use Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Schott Glass Containers for Pharmaceutical Use Sales by Product in 2024
11.2.6 Schott Glass Containers for Pharmaceutical Use Sales by Application in 2024
11.2.7 Schott Glass Containers for Pharmaceutical Use Sales by Geographic Area in 2024
11.2.8 Schott Glass Containers for Pharmaceutical Use SWOT Analysis
11.2.9 Schott Recent Developments
11.3 SGD
11.3.1 SGD Corporation Information
11.3.2 SGD Business Overview
11.3.3 SGD Glass Containers for Pharmaceutical Use Product Models, Descriptions and Specifications
11.3.4 SGD Glass Containers for Pharmaceutical Use Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 SGD Glass Containers for Pharmaceutical Use Sales by Product in 2024
11.3.6 SGD Glass Containers for Pharmaceutical Use Sales by Application in 2024
11.3.7 SGD Glass Containers for Pharmaceutical Use Sales by Geographic Area in 2024
11.3.8 SGD Glass Containers for Pharmaceutical Use SWOT Analysis
11.3.9 SGD Recent Developments
11.4 Nipro
11.4.1 Nipro Corporation Information
11.4.2 Nipro Business Overview
11.4.3 Nipro Glass Containers for Pharmaceutical Use Product Models, Descriptions and Specifications
11.4.4 Nipro Glass Containers for Pharmaceutical Use Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Nipro Glass Containers for Pharmaceutical Use Sales by Product in 2024
11.4.6 Nipro Glass Containers for Pharmaceutical Use Sales by Application in 2024
11.4.7 Nipro Glass Containers for Pharmaceutical Use Sales by Geographic Area in 2024
11.4.8 Nipro Glass Containers for Pharmaceutical Use SWOT Analysis
11.4.9 Nipro Recent Developments
11.5 Stevanato Group
11.5.1 Stevanato Group Corporation Information
11.5.2 Stevanato Group Business Overview
11.5.3 Stevanato Group Glass Containers for Pharmaceutical Use Product Models, Descriptions and Specifications
11.5.4 Stevanato Group Glass Containers for Pharmaceutical Use Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Stevanato Group Glass Containers for Pharmaceutical Use Sales by Product in 2024
11.5.6 Stevanato Group Glass Containers for Pharmaceutical Use Sales by Application in 2024
11.5.7 Stevanato Group Glass Containers for Pharmaceutical Use Sales by Geographic Area in 2024
11.5.8 Stevanato Group Glass Containers for Pharmaceutical Use SWOT Analysis
11.5.9 Stevanato Group Recent Developments
11.6 Shandong PG
11.6.1 Shandong PG Corporation Information
11.6.2 Shandong PG Business Overview
11.6.3 Shandong PG Glass Containers for Pharmaceutical Use Product Models, Descriptions and Specifications
11.6.4 Shandong PG Glass Containers for Pharmaceutical Use Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Shandong PG Recent Developments
11.7 Ardagh
11.7.1 Ardagh Corporation Information
11.7.2 Ardagh Business Overview
11.7.3 Ardagh Glass Containers for Pharmaceutical Use Product Models, Descriptions and Specifications
11.7.4 Ardagh Glass Containers for Pharmaceutical Use Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Ardagh Recent Developments
11.8 Bormioli Pharma
11.8.1 Bormioli Pharma Corporation Information
11.8.2 Bormioli Pharma Business Overview
11.8.3 Bormioli Pharma Glass Containers for Pharmaceutical Use Product Models, Descriptions and Specifications
11.8.4 Bormioli Pharma Glass Containers for Pharmaceutical Use Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Bormioli Pharma Recent Developments
11.9 West Pharmaceutical
11.9.1 West Pharmaceutical Corporation Information
11.9.2 West Pharmaceutical Business Overview
11.9.3 West Pharmaceutical Glass Containers for Pharmaceutical Use Product Models, Descriptions and Specifications
11.9.4 West Pharmaceutical Glass Containers for Pharmaceutical Use Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 West Pharmaceutical Recent Developments
11.10 Sisecam Group
11.10.1 Sisecam Group Corporation Information
11.10.2 Sisecam Group Business Overview
11.10.3 Sisecam Group Glass Containers for Pharmaceutical Use Product Models, Descriptions and Specifications
11.10.4 Sisecam Group Glass Containers for Pharmaceutical Use Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Sisecam Group Recent Developments
11.11 Corning Incorporated
11.11.1 Corning Incorporated Corporation Information
11.11.2 Corning Incorporated Business Overview
11.11.3 Corning Incorporated Glass Containers for Pharmaceutical Use Product Models, Descriptions and Specifications
11.11.4 Corning Incorporated Glass Containers for Pharmaceutical Use Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Corning Incorporated Recent Developments
11.12 PGP Glass
11.12.1 PGP Glass Corporation Information
11.12.2 PGP Glass Business Overview
11.12.3 PGP Glass Glass Containers for Pharmaceutical Use Product Models, Descriptions and Specifications
11.12.4 PGP Glass Glass Containers for Pharmaceutical Use Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 PGP Glass Recent Developments
11.13 Stoelzle Glass
11.13.1 Stoelzle Glass Corporation Information
11.13.2 Stoelzle Glass Business Overview
11.13.3 Stoelzle Glass Glass Containers for Pharmaceutical Use Product Models, Descriptions and Specifications
11.13.4 Stoelzle Glass Glass Containers for Pharmaceutical Use Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Stoelzle Glass Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Glass Containers for Pharmaceutical Use Industry Chain
12.2 Glass Containers for Pharmaceutical Use Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Glass Containers for Pharmaceutical Use Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Glass Containers for Pharmaceutical Use Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Glass Containers for Pharmaceutical Use Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Glass Containers for Pharmaceutical Use Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Glass Containers for Pharmaceutical Use was estimated to be worth US$ 3913 million in 2025 and is projected to reach US$ 5095 million, growing at a CAGR of 3.9% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 144
USD 3950.00
(Single User License)
The global Glass Containers for Pharmaceutical Use market was valued at US$ 3913 million in 2025 and is anticipated to reach US$ 5095 million by 2032, at a CAGR of 3.9% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 123
USD 2900.00
(Single User License)
The global Glass Containers for Pharmaceutical Use market size was US$ 3780 million in 2024 and is forecast to a readjusted size of US$ 4923 million by 2031 with a CAGR of 3.9% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 93
USD 4250.00
(Single User License)
The global market for Glass Containers for Pharmaceutical Use was estimated to be worth US$ 3780 million in 2024 and is forecast to a readjusted size of US$ 4923 million by 2031 with a CAGR of 3.9% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 127
USD 3950.00
(Single User License)
The global market for Glass Containers for Pharmaceutical Use was valued at US$ 3780 million in the year 2024 and is projected to reach a revised size of US$ 4923 million by 2031, growing at a CAGR of 3.9% during the forecast period.
Published Date: 2025-01-13
Pages: 91
USD 2900.00
(Single User License)
Pharmaceutical Glass Packaging has a broad range of containers, including injectable, transfusion, diagnostic and syrup bottles, and offers a choice of glass type (I, II, III) and color (clear or amber) .
Published Date: 2024-01-17
Pages: 93
USD 2900.00
(Single User License)
The global market for Glass Containers for Pharmaceutical Use was estimated to be worth US$ 3913 million in 2025 and is projected to reach US$ 5095 million, growing at a CAGR of 3.9% from 2026 to 2032.
Published: 2026-06-16
Pages: 144
The global Glass Containers for Pharmaceutical Use market was valued at US$ 3913 million in 2025 and is anticipated to reach US$ 5095 million by 2032, at a CAGR of 3.9% from 2026 to 2032.
Published: 2026-04-17
Pages: 123
The global Glass Containers for Pharmaceutical Use market size was US$ 3780 million in 2024 and is forecast to a readjusted size of US$ 4923 million by 2031 with a CAGR of 3.9% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 93
The global market for Glass Containers for Pharmaceutical Use was estimated to be worth US$ 3780 million in 2024 and is forecast to a readjusted size of US$ 4923 million by 2031 with a CAGR of 3.9% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 127
The global market for Glass Containers for Pharmaceutical Use was valued at US$ 3780 million in the year 2024 and is projected to reach a revised size of US$ 4923 million by 2031, growing at a CAGR of 3.9% during the forecast period.
Published: 2025-01-13
Pages: 91
Pharmaceutical Glass Packaging has a broad range of containers, including injectable, transfusion, diagnostic and syrup bottles, and offers a choice of glass type (I, II, III) and color (clear or amber) .
Published: 2024-01-17
Pages: 93
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now